企業一覧に戻る

INTERNATIONAL FLAVORS & FRAGRANCES INCIFF)の決算・業績分析

INTERNATIONAL FLAVORS & FRAGRANCES INCの2025年有価証券報告書をAI分析。売上高$10.9B(-5.2%)。営業利益-$382M。Materials

目次
SUMMARY — 業績サマリー

INTERNATIONAL FLAVORS & FRAGRANCES INC2025年度 業績サマリー

INTERNATIONAL FLAVORS & FRAGRANCES INC(証券コード: IFF)の2025年度決算・業績分析。売上高は$10.9B(前年比-5.2%)。営業利益は-$382M(前年比-149.9%)。純利益は-$359M(前年比-245.3%)。有価証券報告書を基に、業績変化の要因・リスク・見通し・セグメント構成を AI が分析しました。

INTERNATIONAL FLAVORS & FRAGRANCES INC2024年度 注目ポイント

※ 直近の2025年度XBRLデータは取込済みですが、AI分析は2024年度の10-Kを対象としています。

  1. Revenue grew 6.7% YoY to $12.4B (XBRL), but operating income plummeted 326.7% YoY to -$1.3B (XBRL) due to impairment charges and strategic reorganization.
  2. Net debt reached $8.7B (XBRL) with long-term debt at $9.2B (XBRL), despite $483M in cash (XBRL) and a current ratio of 1.67x (XBRL).
  3. R&D investment hit $603M (XBRL), but net income collapsed 768.1% YoY to -$1.9B (XBRL), reflecting significant non-operating losses.

INTERNATIONAL FLAVORS & FRAGRANCES INCの売上高変化の要因

  • FY2024 revenue reached $12.4B (XBRL), a 6.7% YoY increase. Historical data shows revenue grew from $11.7B in FY2023 to $12.4B in FY2024, though FY2025 projections indicate a decline to $11.5B (XBRL). Segment-specific revenue drivers are not disclosed in the provided data (N/A). The 5-year CAGR of 23.6% (XBRL) highlights long-term growth, but FY2024 results reflect strategic reorganization impacts (10-K).

INTERNATIONAL FLAVORS & FRAGRANCES INCの営業利益変化の要因

  • Gross profit was $4.2B (XBRL) with a 33.4% margin (XBRL), but operating income fell to -$1.3B (XBRL) (-10.7% margin, XBRL), a 326.7% YoY decline. Net income collapsed to -$1.9B (XBRL) (-15.0% margin, XBRL), down 768.1% YoY. Key drivers include impairment charges (e.g., $64M for Pharma Solutions, $2.6B for Nourish in prior years, 10-K) and strategic divestitures (10-K).

INTERNATIONAL FLAVORS & FRAGRANCES INCの事業リスクと対応

Substantial indebtedness ($8.7B net debt, $9.2B long-term debt, XBRL) could limit financial flexibility and capital returns (10-K).

Failure to execute strategic transformation (portfolio optimization) risks material operational impacts (10-K).

Regulatory/legal risks from antitrust investigations, lawsuits, and compliance with product safety/environmental laws (10-K).

Supply chain/geopolitical disruptions may affect procurement and operations (10-K).

Inflationary pressures and input cost volatility threaten short-term profitability (10-K).

Intensified focus on sustainability and AI-related risks (10-K).

INTERNATIONAL FLAVORS & FRAGRANCES INCの事業内容

International Flavors & Fragrances Inc (IFF) is a global leader in creating and manufacturing ingredients, flavor compounds, and biotechnology-derived products for food, beverage, health & biosciences, scent, and pharma industries (10-K). Its core segments include Nourish (food & beverage ingredients), Health & Biosciences (enzymes, probiotics), Scent (fragrance compounds), and Pharma Solutions (specialty ingredients). The company serves manufacturers in dairy, personal care, and pharmaceuticals, with no single customer exceeding 10% of sales (10-K). Competitive advantages include a diverse product portfolio, strong R&D investment ($603M in FY2024, XBRL), and global market leadership in key sectors (10-K).

INTERNATIONAL FLAVORS & FRAGRANCES INCのAI業績分析レポート(2024年度)

INTERNATIONAL FLAVORS & FRAGRANCES INC (IFF) FY2024 ANNUAL REPORT ANALYSIS

Highlights

Revenue grew 6.7% YoY to $12.4B (XBRL), but operating income plummeted 326.7% YoY to -$1.3B (XBRL) due to impairment charges and strategic reorganization.
Net debt reached $8.7B (XBRL) with long-term debt at $9.2B (XBRL), despite $483M in cash (XBRL) and a current ratio of 1.67x (XBRL).
R&D investment hit $603M (XBRL), but net income collapsed 768.1% YoY to -$1.9B (XBRL), reflecting significant non-operating losses.

Business Overview

IFF is a global leader in creating and manufacturing ingredients, flavor compounds, and biotechnology-derived products for food, beverage, health & biosciences, scent, and pharma industries (10-K). Its core segments include Nourish (food & beverage ingredients), Health & Biosciences (enzymes, probiotics), Scent (fragrance compounds), and Pharma Solutions (specialty ingredients). The company serves manufacturers in dairy, personal care, and pharmaceuticals, with no single customer exceeding 10% of sales (10-K). Competitive advantages include a diverse product portfolio, strong R&D investment ($603M in FY2024, XBRL), and global market leadership in key sectors (10-K).

Revenue Analysis

FY2024 revenue reached $12.4B (XBRL), a 6.7% YoY increase. Historical data shows revenue grew from $11.7B in FY2023 to $12.4B in FY2024, though FY2025 projections indicate a decline to $11.5B (XBRL). Segment-specific revenue drivers are not disclosed in the provided data (N/A). The 5-year CAGR of 23.6% (XBRL) highlights long-term growth, but FY2024 results reflect strategic reorganization impacts (10-K).

Profitability Analysis

Gross profit was $4.2B (XBRL) with a 33.4% margin (XBRL), but operating income fell to -$1.3B (XBRL) (-10.7% margin, XBRL), a 326.7% YoY decline. Net income collapsed to -$1.9B (XBRL) (-15.0% margin, XBRL), down 768.1% YoY. Key drivers include impairment charges (e.g., $64M for Pharma Solutions, $2.6B for Nourish in prior years, 10-K) and strategic divestitures (10-K).

Balance Sheet Analysis

Total assets declined to $31.0B (XBRL) in FY2024 from $35.5B in FY2023, while total equity fell to $14.6B (XBRL) from $17.7B. Long-term debt rose to $9.2B (XBRL), resulting in net debt of $8.7B (XBRL). Cash reserves stood at $483M (XBRL), with a 47.2% equity ratio (XBRL). The current ratio of 1.67x (XBRL) suggests moderate liquidity.

Cash Flow Analysis

Operating cash flow was $397M (XBRL), but free cash flow turned negative at -$107M (XBRL) due to $504M in CapEx (XBRL). Dividends paid totaled $810M (XBRL), reflecting a payout ratio of -43.5% (XBRL). Investing activities included $745M in proceeds from divestitures (10-K).

Working Capital Analysis

N/A

Risks

1.Substantial indebtedness ($8.7B net debt, $9.2B long-term debt, XBRL) could limit financial flexibility and capital returns (10-K).
2.Failure to execute strategic transformation (portfolio optimization) risks material operational impacts (10-K).
3.Regulatory/legal risks from antitrust investigations, lawsuits, and compliance with product safety/environmental laws (10-K).
4.Supply chain/geopolitical disruptions may affect procurement and operations (10-K).
5.Inflationary pressures and input cost volatility threaten short-term profitability (10-K).
6.Intensified focus on sustainability and AI-related risks (10-K).

Outlook

N/A

Historical Time Series

MetricFY2020FY2021FY2022FY2023FY2024FY2025
Revenue4.0B5.1B5.1B11.7B12.4B11.5B
Operating Income584M665M566M585M-1.3B-2.1B
Net Income340M460M367M279M-1.9B-2.6B
Total Assets13.3B13.6B39.7B35.5B31.0B28.7B
Total Equity6.2B6.3B21.1B17.7B14.6B13.8B
Operating Cash Flow438M699M714M1.4B397M1.5B

Materialsの企業一覧

INTERNATIONAL FLAVORS & FRAGRANCES INCと同じ「Materials」セクターの企業